[11C]Deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain

Xuefeng Yan; Sanjay Telu; Rachel Dick; Jeih-San Liow; Paolo Zanotti-Fregonara; Cheryl Morse; Lester Manly; Robert Gladding; Stal Shrestha; Walter Lerchner; Yuji Nagai; Takafumi Minamimoto; Sami Zoghbi; Robert Innis; Victor Pike; Barry Richmond; Mark Eldridge

Meeting ReportOral - PhysicianPharm

[¹¹C]Deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain

Xuefeng Yan, Sanjay Telu, Rachel Dick, Jeih-San Liow, Paolo Zanotti-Fregonara, Cheryl Morse, Lester Manly, Robert Gladding, Stal Shrestha, Walter Lerchner, Yuji Nagai, Takafumi Minamimoto, Sami Zoghbi, Robert Innis, Victor Pike, Barry Richmond and Mark Eldridge

Journal of Nuclear Medicine May 2021, 62 (supplement 1) 120;

Xuefeng Yan

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sanjay Telu

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rachel Dick

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeih-San Liow

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paolo Zanotti-Fregonara

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cheryl Morse

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lester Manly

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Gladding

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stal Shrestha

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Walter Lerchner

2Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yuji Nagai

3Department of Functional Brain Imaging, National institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology Chiba Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Takafumi Minamimoto

3Department of Functional Brain Imaging, National institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology Chiba Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sami Zoghbi

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Innis

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Victor Pike

1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Barry Richmond

2Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark Eldridge

2Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Information

vol. 62 no. supplement 1 120

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Published online May 18, 2021.

Author Information

Xuefeng Yan₁,
Sanjay Telu₁,
Rachel Dick₁,
Jeih-San Liow₁,
Paolo Zanotti-Fregonara₁,
Cheryl Morse₁,
Lester Manly₁,
Robert Gladding₁,
Stal Shrestha₁,
Walter Lerchner₂,
Yuji Nagai₃,
Takafumi Minamimoto₃,
Sami Zoghbi₁,
Robert Innis₁,
Victor Pike₁,
Barry Richmond₂ and
Mark Eldridge₂

¹Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health Bethesda MD United States
²Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health Bethesda MD United States
³Department of Functional Brain Imaging, National institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology Chiba Japan

Statistics from Altmetric.com

Cited By...

Citations
Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2021 to May 2025

	Abstract	Full	Pdf
May 2021	33	0	0
Jun 2021	44	0	0
Jul 2021	64	0	0
Aug 2021	77	0	0
Sep 2021	21	0	0
Oct 2021	13	0	0
Nov 2021	11	0	0
Dec 2021	14	0	0
Jan 2022	19	0	0
Feb 2022	10	0	0
Mar 2022	55	0	0
Apr 2022	17	0	0
May 2022	9	0	0
Jun 2022	12	0	0
Jul 2022	11	0	0
Aug 2022	5	0	0
Sep 2022	7	0	0
Oct 2022	8	0	0
Nov 2022	6	0	0
Dec 2022	5	0	0
Jan 2023	6	0	0
Feb 2023	5	0	0
Mar 2023	16	0	0
Apr 2023	2	0	0
May 2023	9	0	0
Jun 2023	9	0	0
Jul 2023	10	0	0
Aug 2023	7	0	0
Sep 2023	3	0	0
Oct 2023	3	0	0
Nov 2023	5	0	0
Dec 2023	7	0	0
Jan 2024	11	0	0
Feb 2024	6	0	0
Mar 2024	4	0	0
Apr 2024	23	0	0
May 2024	8	0	0
Jun 2024	26	0	0
Jul 2024	63	0	0
Aug 2024	61	0	0
Sep 2024	12	0	0
Oct 2024	3	0	0
Nov 2024	9	0	0
Dec 2024	5	0	0
Jan 2025	20	0	0
Feb 2025	16	0	0
Mar 2025	15	0	0
Apr 2025	24	0	0

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue supplement 1

May 1, 2021

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following [11C]Deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

[¹¹C]Deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain

Journal of Nuclear Medicine May 2021, 62 (supplement 1) 120;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

[¹¹C]Deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain

Journal of Nuclear Medicine May 2021, 62 (supplement 1) 120;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oral - PhysicianPharm

Volumetric evaluation of ^99mTc-pyrophosphate SPECT/CT in patients with transthyretin cardiac amyloidosis: optimization and correlation with cardiac functional parameters
Preclinical Evaluation of a novel PET Tracer for imaging PARP1 in Glioblastoma
Aspirin blockade of COX-1 in human organs is reduced by plasma as shown by PET imaging and blood assays with ¹¹C-PS13

Show more Oral - PhysicianPharm

Novel Radiotracers and Multi-Modal Imaging of the Brain

[C-11]UCB-J uptake and Ab accumulation across the cognitive spectrum
Associations between ¹¹C-UCB-J source networks and fMRI resting-state networks
Human hippocampal [¹⁸F]nifene binding to nicotinic acetylcholinergic α4β2* receptors is reduced in postmortem Alzheimer’s disease brains

Show more Novel Radiotracers and Multi-Modal Imaging of the Brain

Main menu

User menu

Search

[¹¹C]Deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: May 2021 to May 2025

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oral - PhysicianPharm

Similar Articles